NO20014617L - 1-Arensulfonyl-2-aryl-pyrrolidin- og -piperidin-derivater for behandling av CNS-sykdommer - Google Patents
1-Arensulfonyl-2-aryl-pyrrolidin- og -piperidin-derivater for behandling av CNS-sykdommerInfo
- Publication number
- NO20014617L NO20014617L NO20014617A NO20014617A NO20014617L NO 20014617 L NO20014617 L NO 20014617L NO 20014617 A NO20014617 A NO 20014617A NO 20014617 A NO20014617 A NO 20014617A NO 20014617 L NO20014617 L NO 20014617L
- Authority
- NO
- Norway
- Prior art keywords
- arensulfonyl
- treatment
- piperidine derivatives
- cns diseases
- aryl pyrrolidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
- C07D207/48—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99106004 | 1999-03-25 | ||
| PCT/EP2000/002431 WO2000058285A1 (en) | 1999-03-25 | 2000-03-18 | 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20014617D0 NO20014617D0 (no) | 2001-09-24 |
| NO20014617L true NO20014617L (no) | 2001-09-24 |
| NO319948B1 NO319948B1 (no) | 2005-10-03 |
Family
ID=8237852
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20014617A NO319948B1 (no) | 1999-03-25 | 2001-09-24 | 1-Arensulfonyl-2-aryl-pyrrolidin- og -piperidin-derivater for behandling av CNS-sykdommer |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US6284785B1 (no) |
| EP (1) | EP1165510B1 (no) |
| JP (1) | JP3590589B2 (no) |
| KR (1) | KR100452648B1 (no) |
| CN (1) | CN1150165C (no) |
| AR (1) | AR028817A1 (no) |
| AT (1) | ATE305451T1 (no) |
| AU (1) | AU765212B2 (no) |
| BR (1) | BR0009278A (no) |
| CA (1) | CA2368418C (no) |
| CO (1) | CO5050296A1 (no) |
| CZ (1) | CZ20013402A3 (no) |
| DE (1) | DE60022867T2 (no) |
| DK (1) | DK1165510T3 (no) |
| ES (1) | ES2249249T3 (no) |
| HK (1) | HK1044944B (no) |
| HR (1) | HRP20010682A2 (no) |
| HU (1) | HUP0200284A3 (no) |
| IL (1) | IL145301A0 (no) |
| JO (1) | JO2274B1 (no) |
| MA (1) | MA26779A1 (no) |
| MX (1) | MXPA01009623A (no) |
| MY (1) | MY125295A (no) |
| NO (1) | NO319948B1 (no) |
| NZ (1) | NZ514037A (no) |
| PE (1) | PE20001583A1 (no) |
| PL (1) | PL204436B1 (no) |
| RU (1) | RU2248350C2 (no) |
| SI (1) | SI1165510T1 (no) |
| TR (1) | TR200102789T2 (no) |
| TW (1) | TW575561B (no) |
| WO (1) | WO2000058285A1 (no) |
| YU (1) | YU67601A (no) |
| ZA (1) | ZA200107689B (no) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6589978B2 (en) * | 2000-06-30 | 2003-07-08 | Hoffman-La Roche Inc. | 1-sulfonyl pyrrolidine derivatives |
| US20040267010A1 (en) * | 2001-02-02 | 2004-12-30 | Forbes Ian Thomson | Sulfonamide compounds, their preparation and use |
| TW200302717A (en) * | 2002-02-06 | 2003-08-16 | Schering Corp | Novel gamma secretase inhibitors |
| US20060281803A1 (en) * | 2003-09-23 | 2006-12-14 | Lindsley Craig W | Pyrazole modulators of metabotropic glutamate receptors |
| WO2005113542A2 (en) * | 2004-05-20 | 2005-12-01 | Elan Pharmaceuticals, Inc. | N-cyclic sulfonamido inhibitors of gamma secretase |
| EP1803709B1 (en) | 2004-09-30 | 2013-01-02 | Takeda Pharmaceutical Company Limited | Proton pump inhibitors |
| JP2009506069A (ja) | 2005-08-26 | 2009-02-12 | ブレインセルス，インコーポレイティド | ムスカリン性受容体調節による神経発生 |
| EP2258357A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| EP1919865B1 (en) | 2005-08-30 | 2011-04-06 | Takeda Pharmaceutical Company Limited | 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors |
| AU2006304787A1 (en) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by PDE inhibition |
| US20070112017A1 (en) | 2005-10-31 | 2007-05-17 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| EP2021000A2 (en) | 2006-05-09 | 2009-02-11 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| JP2009536667A (ja) | 2006-05-09 | 2009-10-15 | ブレインセルス，インコーポレイティド | ５ｈｔ受容体介在性の神経新生 |
| US7998971B2 (en) | 2006-09-08 | 2011-08-16 | Braincells Inc. | Combinations containing a 4-acylaminopyridine derivative |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| US8933105B2 (en) | 2007-02-28 | 2015-01-13 | Takeda Pharmaceutical Company Limited | Pyrrole compounds |
| US8969387B2 (en) | 2008-08-27 | 2015-03-03 | Takeda Pharmaceutical Company Limited | Pyrrole compounds |
| WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| GB201702221D0 (en) | 2017-02-10 | 2017-03-29 | Univ Of Sussex | Compounds |
| US10603313B2 (en) * | 2017-07-31 | 2020-03-31 | Chiromics, LLC | Allosteric modulators of the mu opioid receptor |
| GB201803340D0 (en) | 2018-03-01 | 2018-04-18 | Univ Of Sussex | Compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2685325B1 (fr) * | 1991-12-20 | 1994-02-04 | Adir Cie | Nouveaux derives de pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| GB9612884D0 (en) * | 1996-06-20 | 1996-08-21 | Smithkline Beecham Plc | Novel compounds |
-
2000
- 2000-03-13 TW TW89104504A patent/TW575561B/zh active
- 2000-03-18 MX MXPA01009623A patent/MXPA01009623A/es active IP Right Grant
- 2000-03-18 CN CNB008055300A patent/CN1150165C/zh not_active Expired - Fee Related
- 2000-03-18 RU RU2001126570/04A patent/RU2248350C2/ru not_active IP Right Cessation
- 2000-03-18 HU HU0200284A patent/HUP0200284A3/hu unknown
- 2000-03-18 SI SI200030753T patent/SI1165510T1/sl unknown
- 2000-03-18 KR KR10-2001-7012227A patent/KR100452648B1/ko not_active IP Right Cessation
- 2000-03-18 ES ES00910863T patent/ES2249249T3/es not_active Expired - Lifetime
- 2000-03-18 TR TR2001/02789T patent/TR200102789T2/xx unknown
- 2000-03-18 PL PL350679A patent/PL204436B1/pl not_active IP Right Cessation
- 2000-03-18 CA CA002368418A patent/CA2368418C/en not_active Expired - Fee Related
- 2000-03-18 EP EP00910863A patent/EP1165510B1/en not_active Expired - Lifetime
- 2000-03-18 BR BR0009278-9A patent/BR0009278A/pt active Search and Examination
- 2000-03-18 IL IL14530100A patent/IL145301A0/xx unknown
- 2000-03-18 YU YU67601A patent/YU67601A/sh unknown
- 2000-03-18 DK DK00910863T patent/DK1165510T3/da active
- 2000-03-18 DE DE60022867T patent/DE60022867T2/de not_active Expired - Lifetime
- 2000-03-18 WO PCT/EP2000/002431 patent/WO2000058285A1/en not_active Application Discontinuation
- 2000-03-18 JP JP2000607988A patent/JP3590589B2/ja not_active Expired - Fee Related
- 2000-03-18 CZ CZ20013402A patent/CZ20013402A3/cs unknown
- 2000-03-18 AU AU32915/00A patent/AU765212B2/en not_active Ceased
- 2000-03-18 AT AT00910863T patent/ATE305451T1/de active
- 2000-03-20 PE PE2000000241A patent/PE20001583A1/es not_active Application Discontinuation
- 2000-03-22 CO CO00020380A patent/CO5050296A1/es unknown
- 2000-03-23 AR ARP000101297A patent/AR028817A1/es unknown
- 2000-03-23 MY MYPI20001145A patent/MY125295A/en unknown
- 2000-03-23 JO JO200025A patent/JO2274B1/en active
- 2000-03-24 US US09/534,380 patent/US6284785B1/en not_active Expired - Fee Related
-
2001
- 2001-09-17 HR HR20010682A patent/HRP20010682A2/hr not_active Application Discontinuation
- 2001-09-18 ZA ZA200107689A patent/ZA200107689B/xx unknown
- 2001-09-24 NO NO20014617A patent/NO319948B1/no unknown
- 2001-09-25 MA MA26339A patent/MA26779A1/fr unknown
-
2002
- 2002-08-27 HK HK02106320.6A patent/HK1044944B/zh not_active IP Right Cessation
-
2004
- 2004-01-30 NZ NZ514037A patent/NZ514037A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20014617L (no) | 1-Arensulfonyl-2-aryl-pyrrolidin- og -piperidin-derivater for behandling av CNS-sykdommer | |
| DE60105144D1 (de) | Pyrrolidin und piperidin derivate für die behandlung von neurodegenerativen erkrankungen | |
| NO20013380L (no) | 2-aminobenzoksazinonderivater for behandling av fedme | |
| EE200200442A (et) | Piperasiini ja piperidiini derivaadid neuronaalsete kahjustuste raviks | |
| NO20031442D0 (no) | Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer | |
| NO20013381D0 (no) | 2-oksybenzoksazinonderivater for behandling av fedme | |
| NO20015542L (no) | Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner | |
| NO20024775D0 (no) | Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte | |
| NO20014314D0 (no) | Blandinger og metoder for behandling av stafylokokkisk infeksjon | |
| HUP9900927A3 (en) | Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases | |
| NO20023448L (no) | Medikamentkombinasjon for behandling av depresjon og beslektede forstyrrelser omfattende mirtazapin | |
| NO20020784L (no) | Medikament for behandling av brudd | |
| EE04235B1 (et) | Toimeainete, nimelt tetrahüdropüridiinide ja atsetüülkoliinesteraasi inhibiitorite, kombinatsioon Alzheimeri tõve tüüpi seniildementsuse raviks | |
| NO20026005L (no) | Indolderivater nyttige for behandlingen av CNS-forstyrrelser | |
| NO20012612L (no) | Isonipecotamider for behandlingen av integrin-formidlede sykdommer | |
| NO20030127D0 (no) | Indolderivater nyttige for behandling av CNS-forstyrrelser | |
| NO20026148D0 (no) | Medisiner for forhindring og behandling av neurodegenerative sykdommer | |
| NO20026029D0 (no) | Indolderivater nyttige for behandlingen av CNS-forstyrrelser | |
| NO20033290D0 (no) | Pyrrolderivater for behandling av cytokinformidlede sykdommer | |
| NO20014026L (no) | Krampestillende derivater til behandling av betydelig skjelving | |
| NO20026028D0 (no) | Indolderivater nyttige for behandlingen av CNS-forstyrrelser | |
| NO20014476D0 (no) | Behandling av hiatial hernia | |
| NO20014092D0 (no) | Behandling av infertilitet | |
| NO20014093D0 (no) | Behandling av infertilitet | |
| SE9902239D0 (sv) | Kornisch bestående av flera delar |